Insulin Pump Therapy in the Hospital

Area of Science:

• Endocrinology
• Diabetes Management
• Medical Technology

Background:

• Continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, is a standard outpatient treatment for diabetes mellitus.
• Managing diabetes in hospitalized patients often requires adjustments to insulin regimens.
• The use of advanced diabetes technology like insulin pumps in the inpatient setting presents unique challenges and opportunities.

Purpose of the Study:

• To provide an updated summary on the transition of continuous subcutaneous insulin infusion (CSII) therapy from outpatient to inpatient settings.
• To outline essential components for the safe and effective continuation of CSII therapy during hospitalization.
• To inform healthcare providers about best practices for managing patients on insulin pumps admitted to the hospital.

Main Methods:

• Review of current literature and clinical guidelines on CSII therapy in hospitalized patients.
• Analysis of factors contributing to successful inpatient CSII management.
• Synthesis of recommendations for institutional policy development and interdisciplinary communication.

Main Results:

• Continuation of CSII therapy during hospitalization is feasible and beneficial for selected patients.
• Key elements for safe inpatient CSII include appropriate patient selection, established institutional protocols, and robust communication.
• Effective management ensures glycemic control and patient safety, minimizing interruptions in diabetes care.

Conclusions:

• The transition of outpatient CSII therapy to the inpatient setting is achievable with proper planning and execution.
• Implementing clear guidelines and fostering collaboration between patients and healthcare teams are crucial for successful inpatient CSII management.
• This approach supports continuity of care and optimal glycemic control for individuals with diabetes using insulin pumps.